Eterna Therapeutics Insider Bought Shares Worth $394,174, According to a Recent SEC Filing

Important legal information about the email you will be sending. By using this service, you agree to input your real email address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an email. All information you provide will be used by Fidelity solely for the purpose of sending the email on your behalf. The subject line of the email you send will be "Fidelity.com: "

Eterna Therapeutics Insider Bought Shares Worth $394,174, According to a Recent SEC Filing

, MT Newswires - 10:57 AM ET 4/4/2025 default

10:57 AM EDT, 04/04/2025 (MT Newswires) -- Charles Cherington, 10% Owner, on April 02, 2025, executed a purchase for 3,768,397 shares in Eterna Therapeutics (ERNA) for $394,174. Following the Form 4 filing with the SEC, Cherington has control over a total of 20,401,602 common shares of the company, with 20,401,602 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/748592/000110465925032060/xslF345X05/tm2511399-2_4seq1.xml

Price: 0.16, Change: -0.02, Percent Change: -12.15

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.